Verastem reported $57.2M in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
AstraZeneca USD 47.33B 1.33B Mar/2026
Curis USD 5.46M 19.45M Dec/2025
Cytokinetics USD -826.57M 166.94M Mar/2026
Gilead Sciences USD 23.52B 897M Mar/2026
Incyte USD 5.62B 455.37M Mar/2026
Laboratory Of America USD 8.73B 108.8M Mar/2026
Novartis USD 38.93B 7.2B Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Roche Holding CHF 33.8B 758M Dec/2025
TG Therapeutics USD 583.13M 64.89M Mar/2026
Verastem USD 57.2M 72.72M Dec/2025